The association of latent toxoplasmosis with mental disorders in general and with schizophrenia in particular was noticed in the mid-1950s. In subsequent years, the role of Toxoplasma gondii was established based on its ability to survive for long periods of time in the nerve cells of the brain. The acute manifestations of the infection include psychopathic symptoms resembling those of schizophrenia. In the former USSR, and in other parts of the world, a number of studies were performed with respect to the association of latent toxoplasmosis and schizophrenia. However, with the dissolution of the USSR at the beginning of the 1990s, studies on the subject were halted due to financial problems and have resumed only recently. The reasons for the resumption of such studies in contemporary Russia are related to the progressively increasing incidence of schizophrenia over the last 25–30 years in the country. According to official data, approximately 550 000 persons reported suffering from the disease in 2014. There are reasons to believe that this is only a fraction of the real burden of the disease. Economically, it cost the state no less than approximately US $10 billion. The purpose of the study was to identify the level of toxoplasmosis seroprevalence in patients with verified diagnoses of schizophrenia in comparison to healthy people in Moscow City and in the Moscow region. A total of 155 persons constituted the patients group and 152 healthy people were in the control group. An integrated approach to the diagnosis and comparison of data from the entire spectrum of serological markers of infection was used, including the detection of specific IgM and the determination of IgG concentrations. It was found that among persons with neuropsychiatric disorders, the incidence of cases with latent toxoplasmosis was higher than in the control group. The effect of toxoplasmosis was significant and similar for men and women. Further statistical analyses revealed that among patients with a diagnosis of schizophrenia, the incidence of latent toxoplasmosis was significantly higher than in the control group. These data are in agreement with the results of similar studies in other countries.

Presently, many malaria-endemic countries in the world are transitioning towards malaria elimination. Out of the 105 countries with ongoing malaria transmission, 10 countries are classified as being in the pre-elimination phase of malaria control, and 9 countries are in the malaria elimination stage, whereas 7 countries are classified as being in the prevention of introduction phase. Between 2000 and 2015, 17 countries eliminated malaria (i.e., attained zero indigenous cases for 3 years or more). Seven countries were certified by the WHO as having successfully eliminated malaria. The purpose of this review was to analyse the epidemiological characteristics of vivax malaria during the various stages of malaria eradication (elimination) programmes in different countries in the past and present. Experiences of the republics of the former USSR with malaria are interesting, particularly since the data overwhelmingly were published in Russian and might not be known to western readers. Among the most important characteristics of Plasmodium vivax epidemiology at present are changes in the ratio of the short-incubation P. vivax to long-incubation P. vivax, the incidence of severe P. vivax cases, the increased numbers of asymptomatic P. vivax cases, the reduced response to anti-malarials and a few others. Various factors contributing towards the peculiarities of P. vivax epidemiology are discussed.Electronic supplementary materialThe online version of this article (10.1186/s12936-018-2495-y) contains supplementary material, which is available to authorized users.

Dirofilariasis is a helminths vector-borne disease caused by two species of Dirofolaria—D. repens and D. immitis. The former is overwhelmingly associated with human dirofilariasis. The vector of the worm are mosquitoes of the family Culicidae (largely Culex, Aedes and Anopheles). The definitive hosts of Dirofilaria are dogs and to a lesser extent cats. Humans are an accidental host. A total of 1200 human cases caused by Dirofilaria were registered in the territory of the ex-USSR during the period 1915–2016. Zonal differences have been seen in the prevalence of infected dogs and mosquitoes. Studies undertaken in the southern part of the Russian Federation (RF) revealed the prevalence of Dirofilaria in dogs to be 20.8% with wild variations of larva density. Studies carried out in the central part of the RF found that the prevalence of parasites in dogs was 4.1%. Aedes mosquitoes were infected less than Culex and Anopheles mosquitoes. The latter were infected by D. repens more often than Culex and Aedes. Zonal differences were also traced in regard to Dirofilaria prevalence in humans, thus allowing identification of three zones of risk of infection (low, moderate, and stable), reflected in a series of constructed maps. Although Dirofilariasis was known on the territory of Russia from 1915, only sporadic cases of the disease were reported occasionally. Its number was showed an increasing trend only during the 1980s–1990s, reaching the level of hundreds of cases. The majority of cases were confined to the southern parts of Russia with geographic coordinates of 43°–45° on the northern latitude. Comparison of the timing of the global trend of climate warming during the 1990s with the temporal pattern of Dirofilaria on the territory of Russia during the same period demonstrated a close association between two phenomena. With the continuous process of global climate warming, the incidence of dirofilariasis both in man and dogs goes unabated exemplified by the territorial expansion of the disease northwards and eastwards attaining the latitude of 56°–57° on the northern latitude in the European and Asian parts of Russia. It appears that within the period of the last 20–25 years, the population at risk has doubled. Under these circumstances, dirofilariases in Russia should be considered as an emerging public health problem necessitating the establishment of a comprehensive epidemiological monitoring system with strong entomological and veterinary components. Based on the results obtained, an appropriate control intervention could be developed.

Malaria control and preventive activities in the countries of the World Health Organization Region for Europe (WHO/EUR) were strengthened within the framework of the Regional Roll Back Malaria strategy adopted by the member-states at the beginning of the 2000s. A political document “From control to malaria elimination” known as the “Tashkent Declaration” was unanimously endorsed by the member-states of the WHO/EUR with malaria problems in 2005. Since then, considerable progress has been achieved in the countries of the region, signified by the dramatic reduction of malaria incidence in conjunction with the prevention of re-establishment of infection on the territories where malaria was eliminated earlier. Several countries of the region had been certified by the WHO as free of local malaria transmission as a result of the activities of their National Malaria Elimination Programme, Armenia being one of the first in 2011. One of the main lessons learnt during the implementation of the activities by the National Malaria Elimination Programme in Armenia was that the development of an operational plan for malaria elimination required a comprehensive national effort. Full support, both political and financial, from the highest levels of government to smooth coordination between different government ministries, such as Agriculture, Defense, Finance, Health and Policy and Planning and others, was a prerequisite for operational success. The role and place of various partners in the achievement of malaria elimination in the country is discussed in this review. Electronic supplementary material The online version of this article (10.1186/s12936-019-2814-y) contains supplementary material, which is available to authorized users.

Studies carried out in Moscow residents have revealed that the prevalence of chronic toxoplasmosis is very close to those in countries of Eastern and Central Europe. Our findings also demonstrated a statistically significant relationship between the rate of traffic accidents and the seroprevalence of chronic toxoplasmosis in drivers who were held responsible for accidents. The latter was 2.37 times higher in drivers who were involved in road accidents compared with control groups. These results suggest that the consequences of chronic toxoplasmosis (particularly a slower reaction time and decreased concentration) might contribute to the peculiarities of the epidemiology of road traffic accidents in the Russian Federation and might interfere with the successful implementation of the Federal Programme named “Increase road traffic safety”. Suggestions for how to address overcome this problem are discussed in this paper.